Invention Application
- Patent Title: COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3
-
Application No.: US17491420Application Date: 2021-09-30
-
Publication No.: US20220153835A1Publication Date: 2022-05-19
- Inventor: Glenn DRANOFF , Frederic TRIEBEL , Chrystelle BRIGNONE , Walter A. BLATTLER , Jennifer Marie MATARAZA , Catherine Ann SABATOS-PEYTON , Hwai Wen CHANG , Gerhard Johann FREY
- Applicant: NOVARTIS AG , IMMUTEP S.A.S.
- Applicant Address: CH Basel; FR Orsay cedex
- Assignee: NOVARTIS AG,IMMUTEP S.A.S.
- Current Assignee: NOVARTIS AG,IMMUTEP S.A.S.
- Current Assignee Address: CH Basel; FR Orsay cedex
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
Combination therapies comprising antibody molecules that specifically bind to LAG-3 are disclosed. The combination therapies can be used to treat, prevent and/or diagnose cancerous or infectious disorders.
Information query
